Marseille Immunopole ©2019 Legal notice & Privacy statement
To date, The Pioneer Project benefits from the commitment of 11 partner centers.
As COVID19 pandemic continues, all partners remain at work and committed to The Pioneer Project
An update of The Pioneer Project RHU: 104 patients in the biomarker component, 2 patients in the umbrella clinical trial.
MI Day: “MI Day Lung Cancer” on 6 February 2020
Immuno-oncology and lung cancer highlights: episode 2 (Q4 2019)
Update of the Pioneer Project RHU: while 91 patients have already been included in the biomarker component of the project, a first patient is entered in the Pioneer’s clinical trial
Overcome resistance to anti-PD1(L1) immunotherapy: first lung cancer patient enrolled in the Pioneer Project’s clinical trial
An update of The Pioneer Project RHU: A total inclusion of 86 patients in the biomarker component of the project
The RHU progresses as expected with a total inclusion of 79 patients in the biomarker component of the project
The Pioneer Project RHU appoints world-renowned experts to its Scientific Advisory Board
With the commitment of 11 partner centers and 46 patients included in the biomarker component of the project, the RHU has entered a new phase